Cardiomyocytes are a stable cell population with only limited potential for renewal after injury. Tissue regeneration may be due to infiltration of stem cells, which differentiate into cardiomyocytes. We have analysed the influx of stem cells in the heart of patients who received either a gender-mismatched BMT (male donor to female recipient) or a gender-mismatched cardiac transplant (HTX; female donor to male recipient). The proportion of infiltrating cells was determined by Y-chromosome in situ hybridization combined with immunohistochemical cell characterization. In BM transplanted patients and in cardiac allotransplant recipients, cardiomyocytes of apparent BM origin were detected. The proportions were similar in both groups and amounted up to 1% of all cardiomyocytes. The number of stem cell-derived cardiomyocytes did not alter significantly in time, but were relatively high in cases where large numbers of BMderived Y-chromosome-positive infiltrating inflammatory cells were present. The number of Y-chromosome-positive endothelial cells was small and present only in small blood vessels. The number of BM-derived cardiomyocytes in both BMT and HTX is not significantly different between the two types of transplantation and is at most 1%.
Introduction
It is generally believed that cardiomyocytes are a stable population without regenerative potential 1 or with only limited regenerative possibilities. 2, 3 Consequently, the only curative treatment for end-stage heart failure is heart transplantation (HTX).
It has been suggested that myocardial regeneration may occur from stem cells of various sources (embryonic, skeletal myoblasts, haematopoietic stem cells) and such a process has even been proposed as a basis for treatment of myocardial infarction.
1, [4] [5] [6] Local intracardial injection of (genetically engineered) stem cells seems promising in experimental studies, [6] [7] [8] although there is doubt about the therapeutic applicability of such an approach. 9, 10 In some cases, injection of these cells resulted in improvement of haemodynamics without evidence of viable engraftment. 11, 12 The number of human studies on transfer of stem cells and subsequent tracing of these cells is still limited, 4, 13, 14 as tracking of stem cells in vivo is still difficult in humans. 15, 16 Recent studies in patients after HTX or BMT have shown an influx, repopulation and differentiation of BMderived cells in the heart, originating from the cardiac recipient or the BMT donor, respectively. However, the reported number of invading stem cells that, evidently, differentiate into cardiomyocytes varied considerably between the various experimental and human studies. 9, 10, [14] [15] [16] [17] [18] [19] [20] This heterogeneity is most likely the result of an overestimation of host-derived cardiomyocytes, due to the presence of large number of infiltrating host-derived inflammatory cells and/or to the application of a variety of different detection techniques.
Therefore, we have analysed human heart tissue obtained after autopsy of patients who received sex-mismatched cardiac transplant or BMT, using the same set of detection techniques. Cells were characterized by in situ hybridization for the Y-chromosome (a female heart in a male patient in case of HTX and male BM graft in a female patient in case of BMT). To differentiate between the host-and donorderived cardiomyocytes and the origin of other infiltrating (stem cell-derived) cells (endothelial cells, inflammatory cells), in situ hybridization for the Y-chromosome was combined with immunohistochemical (IHC) characterization of the cells such as leukocytes (CD45), T cells (CD3), macrophages (CD68), stem cells and endothelial cells (CD34) and cardiomyocytes (myosin 21 ). This was combined with 3D confocal laser scan microscopy to assign the Y-positive nuclei to a specific cell type. 22 In this study, we confirmed the presence of haematopoietic stem cell-derived cardiomyocytes, leukocytes and endothelial cells in the myocardium of patients after heart transplantation or BM-derived SCT. In addition, we showed that the number of host-derived cardiomyocytes is not significantly different between patients after either type of transplantation and is in the order of 1% at the most.
Materials and methods

Patient material
Paraffin-embedded heart tissue samples were retrieved from the autopsy archives of the Pathology Department in the University Medical Center, Utrecht. Material from seven female BMT patients, who had received male BM grafts, was studied. Two female patients with a gender-matched BMT served as controls. Furthermore, material was obtained from six male HTX patients who had received a female heart. Patient characteristics are summarized in Table 1 . Tissue from two male and two female hearts obtained at autopsy of patients without an HTX or heart disease served as controls. All patients had given permission, prior to transplantation, to use their tissues for research purposes. All tissues were embedded in paraffin and cut in 6 mm thick tissue sections.
Fluorescence in situ hybridization
For the detection of the Y-chromosome in paraffin sections, an SRY probe 23 was used. This probe was labelled with digoxygenin (DIG) using a nick translation kit (Roche, Mannheim, Germany) according to the manufacturer's instructions. FISH was performed as previously described: 24 briefly, 6 mm thick deparaffinized slides were digested in pepsin (0.11 g pepsin (1:10 000; Sigma, Steinheim, Germany)/100 ml glycine/HCl pH 2.0 buffer) for 10 min. After dehydrating the slides and drying, 50 ml of DIG-labelled SRY probe was added and the slides were placed on a 98 1C hotplate for 10 min. Following overnight incubation at 37 1C, the slides were rinsed in 50% formamide/SSC2 Â /Tween and 2 Â SSC/Tween for 15 and 10 min, respectively. Next, the slides were blocked in 5% nonfat blocking reagent in 4 Â SSC and incubated with 100 ml of sheep-anti-DIG, fluorescein isothiocyanate (FITC)-labelled antibody (Roche). After rinsing, nuclei were stained with propidium iodide. FITC and propidium iodide fluorescence were viewed under a standard fluorescence microscope or by confocal laser scan microscopy (CLSM) and scored.
Double FISH/IHC staining
To characterize Y-positive cells in the heart tissues, all tissues were stained both by IHC only, and by a doublestaining combination of FISH with any of the following monoclonal antibodies: CD3 (to characterize T cells; Dakopatts A/S, Glostrup, Denmark), CD34 (stem cells and endothelial cells; Immunotech/Coulter, Marseille, France), CD45 (leukocytes; Dakopatts), CD68 (macrophages; Harlan/Sera, Horst, The Netherlands) and antimyosin (cardiomyocytes; Sigma). Because, most antigens are destroyed by pepsin treatment and an incubation step on a 98 1C hotplate (see above), the slides were pretreated only with a citrate-boiling step. This method appeared not to reduce the number of FISH Y-positive cells. The IHC double staining was performed directly after FISH. The IHC method was done as previously described: 25 briefly, slides were first boiled for 20 min in citrate (1500 ml aquadest/4.41 g tri-sodiumcitrat-2-hydrat; Riedel-de Hae¨n, Seelze, Germany). Subsequently, 100 ml of primary antibody was added per slide and incubated for 60 min. After rinsing in PBS/Tween for signal amplification, slides were incubated with 100 ml of Power Vision for 30 min directed against mouse monoclonal antibody (Immunologic/ Klinipath, Duiven, The Netherlands). Again after PBS/Tween rinsing, 100 ml of 2ml tetramethylrhodamine (TRITC) tyramide reagent in 98 ml amplification diluent (PerkinElmer, Boston, MA, USA) was added per slide and incubated for 20 min. Next, the slides were rinsed in PBS/ Tween and incubated for 3 min with 4,6-diamidino-2-phenylindole (DAPI, 2 mg/ml PBS; Sigma) as a blue nuclear counterstaining. Finally, slides were covered with Vectashield (Brunschwig, Amsterdam, The Netherlands) and a coverslip and sealed with transparent nail polish.
Evaluation of tissues
Stained tissue sections were examined with a standard fluorescence microscope and with an MRC-1000 Laser Scanning Confocal Imaging System (Bio-Rad Microscience, Hercules, CA, USA). The heart tissue slides were blinded and two independent examiners performed the scoring of Y-myosin-and Y-CD34-positive cells. Areas rich in connective tissue and/or areas with dense lymphocytic infiltrates were ignored. A total of 1000 cardiac nuclei per slide were counted using Â 600 magnification in order to see Y-chromosome signals as well as possible. Rigorous criteria were used to determine cardiac muscle cells. The nuclei had to be completely surrounded by myosin and in addition, fibres containing more than one nucleus were excluded. In the same microscopic field, the total number of Y-chromosome-positive cells, other than cardiomyocytes, was counted as well. The efficacy of the Y-chromosome probe was determined by counting both the total number of nuclei in male control heart and the number of those nuclei containing the Y signal.
Statistical analysis A Student's t-test using Prism software was performed for statistical analysis. Data were expressed as mean and P-values. P-values less than 0.05 were considered significant. Table 2 , Y-positive cardiomyocytes were detected in sections from three out of six female BMT patients who had received a male BMT. In the sections from male HTX patients who had received a female heart, five out of six had Y-positive cardiomyocytes. The percentages varied from 0 to 0.8% in all BMT patients and from 0 to 1.3% in all HTX patients. The number of Y-chromosome-positive cardiomyocytes tended to be higher in HTX hearts than in BMT hearts, but the difference in the mean percentage of Y-positive cardiomyocytes in BMT and HTX patients was not significant (P ¼ 0.31).
Results
Y-chromosome-positive cardiomyocytes
In control male tissues, Y-chromosomes were easily detected and depending on the tissue screened varied in the percentage of positive cells. As illustrated in Figure 1 , in tonsil epithelium, a percentage of 70-80 was detected, and in the lymphoid tissue, this was 495% indicating that the percentage of Y-positive cells with a small nucleus is higher than in tissues with large nuclei. As a consequence, in control male hearts, the percentage of Y-positive cardiomyocyte nuclei was 45.9%, indicating that using this procedure about half of the nuclei of the cardiomyocytes had their Y-chromosome outside the plane of the section (Figures 1 and 2c ). In the female hearts used as negative control, no Y-positivity was observed. In transplanted hearts, almost all infiltrated mononuclear cells were Y-positive (Figure 1d ).
Y-chromosome-positive non-cardiomyocytes
In order to compare exogenous cardiomyocytes and influx from non-cardiomyocytes, the total number of Y-positive cells were counted in the myosin-stained slides, in the same fields as the 1000 cardiomyocytes. Table 2 shows that the number of Y-positive non-cardiomyocytes is higher (mean 93.0 in BMT and 117.7 in HTX) than the number of Y-positive cardiomyocytes (mean: 1.7 in BMT and 4.2 in HTX) in the microscopic fields used for counting.
In Figure 3 , the number of Y-positive cardiomyocytes is illustrated as a function of time (nonlinear scale for both BMT and HTX) and compared to the number of Y-positive noncardiomyocytes. This figure shows that there is no increase with time of the number of Y-positive cells; this holds for both cardiomyocytes and the other cells. However, in heart tissue sections that were infiltrated by relatively large number of Y-positive non-cardiomyocytes, there tends to be an increased proportion of positive cardiomyocytes. This was most striking in one BMT recipient (at day 49) and in one HTX recipient (day 949). In the HTX recipient, the high number of infiltrating cells could be explained by an acute vascular rejection. The high number of infiltrating cells in the BMT patient could not be explained.
As shown by double staining with CD45 and Y-FISH, most non-cardiomyocytes with a Y-chromosome were infiltrating leukocytes (Figure 3a) , with a normal distribution of CD3 and CD68 (as described previously by Schuurman et al.
26
). (Figure 4d ). This was most probably a stem cell.
Discussion
This study demonstrates that after BMT and HTX, BMderived cells enter the heart and can differentiate into cardiomyocytes. The numbers would appear to be relatively low (mean 1.7/1000 cardiomyocytes in BMT and 4.2/1000 in HTX), but considering that in a normal male heart about 50% of the cells are not stained by Y-FISH, and the total heart is composed of 6 Â 10 9 cardiomyocytes, the total number of stem cell-derived cardiomyocytes may add up to 2-5 Â 10 7 cardiomyocytes in the hearts of BMT and HTX patients. The apparent lack of a demonstrable Y-chromosome in half of the cells in the sections is due to the location of the Y-chromosome outside the plane of the section (this study and Beltrami et al. ). These numbers are in good agreement with data from the literature, 18, 19, 27 although others have reported significantly higher numbers. 2 These discrepancies may be caused by the differences in tracing method (for example, tracing of prelabelled BM cells), but are more probably due to an overestimation of Y-positive cardiomyocytes among the large number of infiltrating (male) inflammatory cells. A reliable screening method with double staining (FISH combined with immunohistochemical characterization of cells) is therefore required. A three-dimensional screening by confocal laser scan microscopy will also prevent the misinterpretation of infiltrating cells beneath the cardiomyocytes, which otherwise are scored as positive cardiomyocytes. 20 This study indicated that there tends to be a positive correlation between the number of stem cell-derived cardiomyocytes and the proportions of infiltrating cells. Such a cellular infiltrate, occurring during an inflammatory response, may take with it a certain number of stem cells, which ultimately can differentiate into cardiomyocytes. In conflict with this suggestion, however, is the lack of CD34-positive stem cells in these infiltrates.
The Y-chromosome-positive cardiomyocytes have a mature morphology and are, evidently, incorporated in the normal cardiac structures. This suggests that these cardiomyocytes are fully functional. Interestingly, the number of Y-positive cardiomyocytes did not increase over time either in the BMT patients or in the HTX patients. We were unable to screen patients individually at several time points, but only as a group. In the patients studied at different times after HTX or BMT, the numbers did not significantly increase over time. The final level of Y-chromosome positive cells seemed to be reached already shortly after transplantation and not to increase further after longer periods of time. A similar observation was made by Minami et al. 27 This suggests that differentiation of bone marrow-derived stem cells does take place, but that these cells are either short lived and are possibly replaced by stem cells from the heart itself (organ-specific stem cells 28 ), or that the BM-derived stem cells only enter the heart under particular circumstances and then remain stable at that level. Another explanation may be the reduced circulation of progenitor cells due to the immunosuppression. 29 This is one of the first papers studying the influx of stem cells that differentiate into cardiomyocytes in gendermismatched recipients of HTX and BMT. Interestingly, the number of Y-positive cardiomyocytes did not increase overtime both in BMT and HTX patients and furthermore, we did not find a significant difference between the BMT and HTX hearts in the number of cardiomyocytes derived from BM stem cells. This was also observed recently by Thiele et al. 30 In our study, there was a tendency towards higher number of stem cell-derived Y-positive cardiomyocytes in the HTX patient group. This might indicate that the damage inflicted on the heart during the HTX procedure (ischaemia and reperfusion damage) is greater than in the heart after BMT. Also, the correlation between large number of inflammatory cells and relative high number of Y-chromosome-positive cardiomyocytes strengthens this assumption. The inflicted damage requires repair and, therefore, more stem cells are supposedly needed to help this process.
Many other host-or BM-derived cells were observed in hearts after both HTX and BMT. In the first place, many Y-chromosome inflammatory mononuclear cells were observed, especially in the transplanted hearts. The composition of the infiltrate was similar to what was observed previously by our group. 26, 31 Another major cell population that was often positive for the Y-chromosome was CD34-positive endothelial cells. 27, 30 Interestingly, these Y-chromosome þ CD34 þ endothelial cells were not observed in the larger blood vessels, but only in small capillaries (this study and Minami et al.
27
). We cannot exclude that lymphocytes migrating through the endothelium contributed to the observed positivity of the endothelial cells, since the infiltrating cells are often found wedged in between the endothelial cells. However, in the endothelial cells that were counted as Y-positive, CD34 positivity was completely enclosing the Y-chromosome-positive nucleus. The relative small number of CD34-positive endothelial cells is in contrast to other studies in which quite high number of circulating endothelial cells were counted that were repopulating blood vessels in organ-and BM transplant recipients. 27, [32] [33] [34] In summary, this study indicates that the number of host-derived cardiomyocytes in both BMT and HTX is not significantly different between both types of transplantation, and that it is at most 1% of the total number of cardiomyocytes. 
